Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Angiography | 14 | 2015 | 1434 | 1.440 |
Why?
|
Pulmonary Veins | 10 | 2015 | 758 | 1.200 |
Why?
|
Heart Atria | 9 | 2013 | 1361 | 0.790 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 4 | 2023 | 238 | 0.680 |
Why?
|
Salicylates | 2 | 2017 | 128 | 0.650 |
Why?
|
Atrial Fibrillation | 15 | 2018 | 5176 | 0.630 |
Why?
|
Magnetic Resonance Imaging, Cine | 10 | 2019 | 1092 | 0.600 |
Why?
|
Spironolactone | 1 | 2021 | 415 | 0.560 |
Why?
|
Myocardial Perfusion Imaging | 5 | 2021 | 672 | 0.520 |
Why?
|
Catheter Ablation | 7 | 2015 | 2780 | 0.490 |
Why?
|
Technetium Tc 99m Sestamibi | 2 | 2013 | 184 | 0.470 |
Why?
|
Phlebography | 1 | 2015 | 326 | 0.450 |
Why?
|
Contrast Media | 12 | 2016 | 5334 | 0.430 |
Why?
|
Magnetic Resonance Imaging | 22 | 2023 | 36854 | 0.430 |
Why?
|
Gadolinium DTPA | 5 | 2012 | 823 | 0.410 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2015 | 696 | 0.410 |
Why?
|
Atrial Flutter | 2 | 2004 | 253 | 0.380 |
Why?
|
Personnel, Hospital | 1 | 2013 | 285 | 0.360 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2019 | 2056 | 0.360 |
Why?
|
Atrial Function, Left | 2 | 2011 | 188 | 0.350 |
Why?
|
Imaging, Three-Dimensional | 11 | 2023 | 4076 | 0.350 |
Why?
|
Image Enhancement | 10 | 2014 | 2898 | 0.340 |
Why?
|
Image Interpretation, Computer-Assisted | 7 | 2014 | 3411 | 0.330 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2004 | 775 | 0.330 |
Why?
|
Cicatrix | 4 | 2013 | 799 | 0.330 |
Why?
|
Arrhythmias, Cardiac | 4 | 2021 | 2258 | 0.330 |
Why?
|
Head and Neck Neoplasms | 2 | 2014 | 2931 | 0.320 |
Why?
|
Overweight | 2 | 2017 | 2448 | 0.300 |
Why?
|
Microscopic Polyangiitis | 2 | 2023 | 46 | 0.300 |
Why?
|
Coronary Vessels | 4 | 2010 | 3124 | 0.300 |
Why?
|
Immunosuppressive Agents | 5 | 2015 | 4207 | 0.300 |
Why?
|
Coronary Artery Disease | 11 | 2021 | 6569 | 0.300 |
Why?
|
Artifacts | 6 | 2020 | 1942 | 0.300 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2014 | 4064 | 0.290 |
Why?
|
Losartan | 1 | 2008 | 262 | 0.270 |
Why?
|
Ventricular Function, Left | 8 | 2021 | 3941 | 0.270 |
Why?
|
Electrocardiography | 12 | 2021 | 6413 | 0.270 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2276 | 0.260 |
Why?
|
Cerebrovascular Disorders | 1 | 2013 | 1486 | 0.260 |
Why?
|
Coronary Disease | 7 | 2022 | 5919 | 0.260 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 428 | 0.260 |
Why?
|
Cerebrovascular Circulation | 2 | 2013 | 2734 | 0.250 |
Why?
|
Myocardial Contraction | 2 | 2011 | 1526 | 0.250 |
Why?
|
Amiodarone | 2 | 2004 | 217 | 0.250 |
Why?
|
Exercise Test | 4 | 2019 | 2187 | 0.250 |
Why?
|
Outpatients | 3 | 2015 | 1603 | 0.240 |
Why?
|
Coronary Thrombosis | 1 | 2008 | 440 | 0.240 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2005 | 64 | 0.240 |
Why?
|
Plaque, Atherosclerotic | 1 | 2016 | 1550 | 0.240 |
Why?
|
Heart | 5 | 2020 | 4447 | 0.240 |
Why?
|
Middle Aged | 61 | 2023 | 223737 | 0.230 |
Why?
|
Radiation Dosage | 1 | 2013 | 1970 | 0.230 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 5 | 2019 | 1141 | 0.230 |
Why?
|
Pulmonary Eosinophilia | 1 | 2004 | 78 | 0.220 |
Why?
|
Churg-Strauss Syndrome | 1 | 2004 | 75 | 0.220 |
Why?
|
Leukotriene Antagonists | 1 | 2004 | 124 | 0.220 |
Why?
|
Neovascularization, Pathologic | 1 | 2014 | 2634 | 0.220 |
Why?
|
Predictive Value of Tests | 14 | 2021 | 15471 | 0.220 |
Why?
|
Cardiac Volume | 1 | 2004 | 197 | 0.210 |
Why?
|
Radiographic Image Enhancement | 2 | 2007 | 877 | 0.210 |
Why?
|
Male | 72 | 2023 | 365203 | 0.210 |
Why?
|
Acetates | 1 | 2004 | 317 | 0.210 |
Why?
|
Lymph Nodes | 1 | 2014 | 3473 | 0.200 |
Why?
|
B-Lymphocytes | 2 | 2015 | 4794 | 0.200 |
Why?
|
Ventricular Dysfunction, Left | 5 | 2019 | 2145 | 0.200 |
Why?
|
Angina Pectoris | 2 | 2019 | 957 | 0.200 |
Why?
|
Aged | 43 | 2023 | 171786 | 0.190 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6401 | 0.190 |
Why?
|
Obesity | 5 | 2016 | 13091 | 0.190 |
Why?
|
Patient Identification Systems | 1 | 2001 | 75 | 0.190 |
Why?
|
Echocardiography, Doppler | 3 | 2019 | 898 | 0.190 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2013 | 2831 | 0.180 |
Why?
|
Coronary Angiography | 9 | 2021 | 4541 | 0.180 |
Why?
|
Female | 68 | 2021 | 397515 | 0.180 |
Why?
|
Defibrillators, Implantable | 4 | 2015 | 1498 | 0.180 |
Why?
|
Humans | 90 | 2023 | 768970 | 0.180 |
Why?
|
Sensitivity and Specificity | 11 | 2014 | 14752 | 0.170 |
Why?
|
Gadolinium | 4 | 2013 | 965 | 0.170 |
Why?
|
Blood Flow Velocity | 3 | 2013 | 1376 | 0.170 |
Why?
|
Aortic Valve Insufficiency | 2 | 2019 | 577 | 0.170 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2022 | 3253 | 0.170 |
Why?
|
Leg Injuries | 1 | 2021 | 180 | 0.170 |
Why?
|
Myocardium | 4 | 2018 | 4790 | 0.160 |
Why?
|
Myocardial Ischemia | 2 | 2013 | 2139 | 0.160 |
Why?
|
Soccer | 1 | 2021 | 142 | 0.160 |
Why?
|
Reproducibility of Results | 11 | 2019 | 20245 | 0.160 |
Why?
|
Glucose Transporter Type 1 | 1 | 2019 | 186 | 0.160 |
Why?
|
Antihypertensive Agents | 1 | 2008 | 2027 | 0.160 |
Why?
|
Quinolines | 1 | 2004 | 772 | 0.160 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2012 | 534 | 0.160 |
Why?
|
Cardiomyopathies | 3 | 2021 | 2057 | 0.150 |
Why?
|
Kidney Diseases | 3 | 2022 | 2100 | 0.150 |
Why?
|
Ventricular Remodeling | 2 | 2019 | 1282 | 0.140 |
Why?
|
Lectins | 1 | 2019 | 490 | 0.140 |
Why?
|
Stroke Volume | 5 | 2021 | 5622 | 0.140 |
Why?
|
Stents | 2 | 2008 | 3200 | 0.140 |
Why?
|
Diabetic Angiopathies | 2 | 2012 | 806 | 0.140 |
Why?
|
Cardiac-Gated Imaging Techniques | 3 | 2013 | 139 | 0.140 |
Why?
|
Treatment Outcome | 17 | 2019 | 65480 | 0.140 |
Why?
|
Hypertrophy, Left Ventricular | 3 | 2018 | 856 | 0.130 |
Why?
|
Heart Failure | 1 | 2021 | 11879 | 0.130 |
Why?
|
Adult | 38 | 2023 | 223851 | 0.130 |
Why?
|
Inflammation | 1 | 2016 | 10868 | 0.130 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2008 | 2763 | 0.130 |
Why?
|
Cardiac Imaging Techniques | 1 | 2018 | 280 | 0.130 |
Why?
|
Cardiomyopathy, Hypertrophic | 3 | 2011 | 1335 | 0.130 |
Why?
|
Coronary Stenosis | 1 | 2021 | 802 | 0.130 |
Why?
|
Sarcoidosis | 1 | 2021 | 535 | 0.120 |
Why?
|
Tachycardia, Sinus | 1 | 2015 | 43 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 8 | 2015 | 20776 | 0.120 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2013 | 12253 | 0.120 |
Why?
|
Respiratory-Gated Imaging Techniques | 2 | 2012 | 75 | 0.120 |
Why?
|
Mycophenolic Acid | 2 | 2022 | 348 | 0.120 |
Why?
|
Image Processing, Computer-Assisted | 8 | 2020 | 9080 | 0.120 |
Why?
|
Mitral Valve Prolapse | 1 | 2016 | 213 | 0.120 |
Why?
|
Tachycardia, Ventricular | 2 | 2015 | 1309 | 0.120 |
Why?
|
Prospective Studies | 15 | 2023 | 54962 | 0.120 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2019 | 2171 | 0.110 |
Why?
|
Meglumine | 2 | 2013 | 144 | 0.110 |
Why?
|
Pericardium | 1 | 2018 | 679 | 0.110 |
Why?
|
Electrocardiography, Ambulatory | 3 | 2011 | 582 | 0.110 |
Why?
|
Molecular Imaging | 1 | 2020 | 826 | 0.110 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 2013 | 76 | 0.110 |
Why?
|
Fats | 1 | 2014 | 99 | 0.110 |
Why?
|
Coronary Aneurysm | 2 | 2008 | 234 | 0.110 |
Why?
|
Genetic Association Studies | 3 | 2019 | 2748 | 0.110 |
Why?
|
Heart Valves | 1 | 2015 | 284 | 0.110 |
Why?
|
Hypertension | 3 | 2011 | 8617 | 0.110 |
Why?
|
Chest Pain | 2 | 2012 | 1101 | 0.100 |
Why?
|
Lymphocyte Depletion | 1 | 2015 | 605 | 0.100 |
Why?
|
Allergy and Immunology | 1 | 2014 | 175 | 0.100 |
Why?
|
Radiopharmaceuticals | 3 | 2019 | 2734 | 0.100 |
Why?
|
Multivariate Analysis | 4 | 2015 | 12095 | 0.100 |
Why?
|
Time Factors | 10 | 2015 | 40261 | 0.100 |
Why?
|
Motion | 2 | 2013 | 794 | 0.100 |
Why?
|
Supine Position | 2 | 2019 | 208 | 0.100 |
Why?
|
Alzheimer Disease | 1 | 2013 | 8760 | 0.090 |
Why?
|
Remission Induction | 2 | 2015 | 2408 | 0.090 |
Why?
|
Prediabetic State | 1 | 2017 | 548 | 0.090 |
Why?
|
Recurrence | 4 | 2015 | 8513 | 0.090 |
Why?
|
Renal Dialysis | 1 | 2021 | 1789 | 0.090 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2013 | 640 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 4 | 2015 | 6547 | 0.090 |
Why?
|
Organometallic Compounds | 2 | 2013 | 648 | 0.090 |
Why?
|
Hemoptysis | 1 | 2012 | 152 | 0.090 |
Why?
|
Athletic Injuries | 1 | 2021 | 1245 | 0.090 |
Why?
|
Acute Coronary Syndrome | 2 | 2015 | 2194 | 0.090 |
Why?
|
Nephrology | 1 | 2014 | 270 | 0.090 |
Why?
|
Cholesterol, HDL | 2 | 2022 | 1820 | 0.090 |
Why?
|
Pyrophosphatases | 1 | 2011 | 142 | 0.090 |
Why?
|
General Practice | 1 | 2011 | 101 | 0.090 |
Why?
|
Mortality | 1 | 2001 | 2914 | 0.090 |
Why?
|
Boston | 6 | 2016 | 9377 | 0.090 |
Why?
|
Coronary Circulation | 2 | 2013 | 1617 | 0.090 |
Why?
|
Surgery, Computer-Assisted | 2 | 2008 | 1006 | 0.090 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2011 | 205 | 0.080 |
Why?
|
Electric Countershock | 1 | 2013 | 534 | 0.080 |
Why?
|
Databases, Factual | 3 | 2016 | 8094 | 0.080 |
Why?
|
Troponin T | 1 | 2015 | 787 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2015 | 1194 | 0.080 |
Why?
|
Bone Marrow Transplantation | 2 | 2007 | 2709 | 0.080 |
Why?
|
Switzerland | 2 | 2014 | 323 | 0.080 |
Why?
|
Vascular System Injuries | 1 | 2013 | 248 | 0.080 |
Why?
|
Aortic Valve | 1 | 2019 | 1969 | 0.080 |
Why?
|
Echocardiography | 2 | 2013 | 5047 | 0.080 |
Why?
|
Pilot Projects | 5 | 2019 | 8748 | 0.080 |
Why?
|
Azathioprine | 1 | 2010 | 354 | 0.080 |
Why?
|
Prognosis | 6 | 2023 | 30046 | 0.080 |
Why?
|
Algorithms | 7 | 2018 | 14201 | 0.080 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2011 | 558 | 0.080 |
Why?
|
Echocardiography, Transesophageal | 1 | 2015 | 1096 | 0.080 |
Why?
|
Glomerular Filtration Rate | 3 | 2012 | 2228 | 0.080 |
Why?
|
Primary Prevention | 2 | 2013 | 1187 | 0.080 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2011 | 706 | 0.080 |
Why?
|
Retrospective Studies | 13 | 2019 | 81903 | 0.080 |
Why?
|
Albuminuria | 1 | 2012 | 658 | 0.080 |
Why?
|
Mitral Valve Insufficiency | 2 | 2010 | 1415 | 0.080 |
Why?
|
Rheumatology | 1 | 2014 | 617 | 0.080 |
Why?
|
Observer Variation | 3 | 2019 | 2623 | 0.070 |
Why?
|
Aged, 80 and over | 10 | 2014 | 59739 | 0.070 |
Why?
|
Magnetics | 1 | 2011 | 599 | 0.070 |
Why?
|
Myocardial Infarction | 3 | 2015 | 11521 | 0.070 |
Why?
|
Cyclophosphamide | 2 | 2010 | 2227 | 0.070 |
Why?
|
Severity of Illness Index | 9 | 2019 | 15951 | 0.070 |
Why?
|
Glutamic Acid | 1 | 2013 | 1191 | 0.070 |
Why?
|
Statistics, Nonparametric | 3 | 2012 | 2862 | 0.070 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2010 | 366 | 0.070 |
Why?
|
Fatty Liver | 1 | 2014 | 810 | 0.070 |
Why?
|
Glucose | 1 | 2019 | 4352 | 0.070 |
Why?
|
Heart Valve Diseases | 1 | 2015 | 1030 | 0.070 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2007 | 109 | 0.070 |
Why?
|
Internal Medicine | 1 | 2014 | 1064 | 0.070 |
Why?
|
Tumor Burden | 1 | 2013 | 1913 | 0.070 |
Why?
|
Respiratory Mechanics | 1 | 2011 | 722 | 0.070 |
Why?
|
Aortic Diseases | 1 | 2013 | 741 | 0.070 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2006 | 139 | 0.070 |
Why?
|
Diastole | 2 | 2011 | 785 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 4 | 2019 | 18068 | 0.070 |
Why?
|
Adipose Tissue | 1 | 2018 | 3335 | 0.070 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2008 | 262 | 0.070 |
Why?
|
Brain | 1 | 2013 | 27453 | 0.070 |
Why?
|
Lymphatic Metastasis | 1 | 2014 | 2916 | 0.060 |
Why?
|
Risk Factors | 11 | 2017 | 74976 | 0.060 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2011 | 560 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2013 | 16053 | 0.060 |
Why?
|
Double-Blind Method | 2 | 2017 | 12467 | 0.060 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2006 | 241 | 0.060 |
Why?
|
Feasibility Studies | 4 | 2019 | 5323 | 0.060 |
Why?
|
Aorta | 1 | 2013 | 2046 | 0.060 |
Why?
|
Italy | 3 | 2011 | 856 | 0.060 |
Why?
|
Death, Sudden, Cardiac | 1 | 2013 | 1568 | 0.060 |
Why?
|
Thallium | 1 | 2004 | 100 | 0.060 |
Why?
|
Guideline Adherence | 1 | 2015 | 2241 | 0.060 |
Why?
|
Positron-Emission Tomography | 2 | 2019 | 6673 | 0.060 |
Why?
|
Diabetes Complications | 1 | 2011 | 1320 | 0.060 |
Why?
|
Incidental Findings | 1 | 2009 | 697 | 0.060 |
Why?
|
Cardiovascular Diseases | 4 | 2017 | 15661 | 0.060 |
Why?
|
Lung Diseases | 2 | 2012 | 1944 | 0.060 |
Why?
|
Carotid Artery Diseases | 1 | 2010 | 878 | 0.060 |
Why?
|
Prone Position | 1 | 2005 | 203 | 0.060 |
Why?
|
Body Size | 1 | 2006 | 463 | 0.060 |
Why?
|
Myocardial Revascularization | 1 | 2007 | 796 | 0.050 |
Why?
|
Registries | 2 | 2015 | 8384 | 0.050 |
Why?
|
Sulfides | 1 | 2004 | 171 | 0.050 |
Why?
|
Heart Rate | 1 | 2015 | 4217 | 0.050 |
Why?
|
Drug Therapy, Combination | 3 | 2014 | 6320 | 0.050 |
Why?
|
Heart Conduction System | 1 | 2008 | 1009 | 0.050 |
Why?
|
Risk Assessment | 8 | 2019 | 24333 | 0.050 |
Why?
|
Triglycerides | 1 | 2011 | 2464 | 0.050 |
Why?
|
Acute Disease | 3 | 2008 | 7245 | 0.050 |
Why?
|
Cyclopropanes | 1 | 2004 | 437 | 0.050 |
Why?
|
Blood Glucose | 1 | 2017 | 6435 | 0.050 |
Why?
|
Case-Control Studies | 7 | 2019 | 22296 | 0.050 |
Why?
|
Movement | 2 | 2011 | 1490 | 0.050 |
Why?
|
Postoperative Care | 1 | 2009 | 1481 | 0.050 |
Why?
|
Young Adult | 9 | 2021 | 60131 | 0.050 |
Why?
|
Social Security | 1 | 2001 | 101 | 0.050 |
Why?
|
Bradycardia | 1 | 2003 | 305 | 0.050 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2023 | 297 | 0.050 |
Why?
|
Radiosurgery | 1 | 2010 | 1346 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2911 | 0.050 |
Why?
|
Antirheumatic Agents | 1 | 2010 | 1381 | 0.040 |
Why?
|
Apolipoprotein A-I | 1 | 2022 | 305 | 0.040 |
Why?
|
Laser Therapy | 1 | 2007 | 1110 | 0.040 |
Why?
|
Ambulatory Care | 1 | 2011 | 2784 | 0.040 |
Why?
|
Cardiology | 1 | 2011 | 1701 | 0.040 |
Why?
|
Incidence | 4 | 2011 | 21547 | 0.040 |
Why?
|
Follow-Up Studies | 7 | 2015 | 39394 | 0.040 |
Why?
|
Hemorrhage | 1 | 2012 | 3466 | 0.040 |
Why?
|
Coronary Vessel Anomalies | 1 | 2003 | 308 | 0.040 |
Why?
|
Graft Occlusion, Vascular | 1 | 2003 | 538 | 0.040 |
Why?
|
Genotype | 4 | 2019 | 13048 | 0.040 |
Why?
|
Radionuclide Imaging | 3 | 2013 | 1998 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2004 | 1626 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8055 | 0.040 |
Why?
|
Bariatric Surgery | 1 | 2009 | 1001 | 0.040 |
Why?
|
Linear Models | 2 | 2011 | 5891 | 0.040 |
Why?
|
Chi-Square Distribution | 1 | 2004 | 3438 | 0.040 |
Why?
|
Purines | 1 | 2021 | 615 | 0.040 |
Why?
|
Logistic Models | 3 | 2011 | 13318 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2013 | 15889 | 0.040 |
Why?
|
Liver | 1 | 2014 | 7578 | 0.040 |
Why?
|
Coronary Artery Bypass | 2 | 2007 | 2194 | 0.040 |
Why?
|
Radiography, Thoracic | 1 | 2004 | 1321 | 0.040 |
Why?
|
Biological Transport | 1 | 2022 | 2085 | 0.040 |
Why?
|
Weight Loss | 1 | 2009 | 2721 | 0.040 |
Why?
|
Lipoproteins | 1 | 2022 | 880 | 0.030 |
Why?
|
Insulin Resistance | 1 | 2011 | 3982 | 0.030 |
Why?
|
Cognition | 1 | 2014 | 7081 | 0.030 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 26395 | 0.030 |
Why?
|
Adolescent | 7 | 2023 | 89244 | 0.030 |
Why?
|
Kidney | 1 | 2012 | 7058 | 0.030 |
Why?
|
Patient Positioning | 1 | 2019 | 332 | 0.030 |
Why?
|
Heart Diseases | 1 | 2009 | 2819 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5892 | 0.030 |
Why?
|
Infusions, Intravenous | 2 | 2010 | 2231 | 0.030 |
Why?
|
Recovery of Function | 2 | 2019 | 2990 | 0.030 |
Why?
|
Heart Ventricles | 1 | 2007 | 3840 | 0.030 |
Why?
|
Chronic Disease | 3 | 2019 | 9384 | 0.030 |
Why?
|
Blood Sedimentation | 1 | 2014 | 236 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9264 | 0.030 |
Why?
|
Equipment Design | 2 | 2011 | 3530 | 0.030 |
Why?
|
Placebos | 1 | 2017 | 1667 | 0.030 |
Why?
|
Blood Pressure | 1 | 2008 | 8544 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2913 | 0.030 |
Why?
|
Respiration | 2 | 2011 | 1668 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2013 | 12562 | 0.030 |
Why?
|
Phenotype | 3 | 2019 | 16731 | 0.020 |
Why?
|
Water | 1 | 2018 | 1421 | 0.020 |
Why?
|
Disease-Free Survival | 2 | 2013 | 6856 | 0.020 |
Why?
|
Hong Kong | 1 | 2011 | 170 | 0.020 |
Why?
|
Genetic Testing | 2 | 2019 | 3591 | 0.020 |
Why?
|
Atherosclerosis | 1 | 2007 | 3431 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10765 | 0.020 |
Why?
|
Pyrazoles | 1 | 2021 | 2029 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3215 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11116 | 0.020 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2011 | 122 | 0.020 |
Why?
|
Survival Analysis | 1 | 2003 | 10115 | 0.020 |
Why?
|
Glutamine | 1 | 2013 | 578 | 0.020 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2010 | 39 | 0.020 |
Why?
|
Glomerulonephritis | 1 | 2012 | 333 | 0.020 |
Why?
|
Cohort Studies | 3 | 2011 | 41808 | 0.020 |
Why?
|
Utilization Review | 1 | 2011 | 384 | 0.020 |
Why?
|
Prednisolone | 1 | 2010 | 327 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2018 | 2533 | 0.020 |
Why?
|
Lung | 2 | 2007 | 10099 | 0.020 |
Why?
|
Internet | 1 | 2001 | 3112 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2010 | 417 | 0.020 |
Why?
|
Fibrosis | 1 | 2016 | 2080 | 0.020 |
Why?
|
Angiography, Digital Subtraction | 1 | 2010 | 332 | 0.020 |
Why?
|
Methylprednisolone | 1 | 2010 | 386 | 0.020 |
Why?
|
Odds Ratio | 2 | 2011 | 9684 | 0.020 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2019 | 1568 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2011 | 848 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4785 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6901 | 0.020 |
Why?
|
Survival Rate | 2 | 2013 | 12873 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2011 | 1586 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2013 | 1209 | 0.020 |
Why?
|
Antimalarials | 1 | 2014 | 909 | 0.020 |
Why?
|
Proteinuria | 1 | 2010 | 610 | 0.020 |
Why?
|
Systole | 1 | 2010 | 937 | 0.020 |
Why?
|
Triiodobenzoic Acids | 1 | 2007 | 123 | 0.020 |
Why?
|
Age Factors | 1 | 2004 | 18435 | 0.020 |
Why?
|
Child | 4 | 2023 | 80960 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2011 | 990 | 0.020 |
Why?
|
Age of Onset | 1 | 2014 | 3346 | 0.020 |
Why?
|
ROC Curve | 1 | 2015 | 3629 | 0.020 |
Why?
|
Pleural Diseases | 1 | 2007 | 138 | 0.020 |
Why?
|
Propensity Score | 1 | 2014 | 1968 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2011 | 2000 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 2011 | 846 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4978 | 0.020 |
Why?
|
Health Resources | 1 | 2012 | 951 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2013 | 2126 | 0.020 |
Why?
|
Aortography | 1 | 2007 | 422 | 0.020 |
Why?
|
Hematoma | 1 | 2010 | 768 | 0.020 |
Why?
|
Cerebral Infarction | 1 | 2010 | 975 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 1892 | 0.020 |
Why?
|
Sodium Chloride | 1 | 2007 | 584 | 0.020 |
Why?
|
Asthma | 1 | 2004 | 6293 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2011 | 1196 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2011 | 2108 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2014 | 1673 | 0.010 |
Why?
|
Postoperative Period | 1 | 2010 | 1830 | 0.010 |
Why?
|
Gene Frequency | 1 | 2011 | 3626 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2010 | 1476 | 0.010 |
Why?
|
Reference Values | 1 | 2011 | 4940 | 0.010 |
Why?
|
Genome-Wide Association Study | 2 | 2013 | 12801 | 0.010 |
Why?
|
Carotid Stenosis | 1 | 2010 | 862 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2008 | 1243 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2664 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2007 | 2126 | 0.010 |
Why?
|
Body Mass Index | 2 | 2011 | 13055 | 0.010 |
Why?
|
Hospitals | 1 | 2015 | 3904 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9621 | 0.010 |
Why?
|
Patient Selection | 1 | 2013 | 4265 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2010 | 2167 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4251 | 0.010 |
Why?
|
Child, Preschool | 1 | 2023 | 42683 | 0.010 |
Why?
|
United States | 2 | 2013 | 73186 | 0.010 |
Why?
|
Computational Biology | 1 | 2011 | 3562 | 0.010 |
Why?
|
Rest | 1 | 2004 | 951 | 0.010 |
Why?
|
Vascular Diseases | 1 | 2007 | 1163 | 0.010 |
Why?
|
Health Care Costs | 1 | 2012 | 3270 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 2007 | 1945 | 0.010 |
Why?
|
Calcinosis | 1 | 2007 | 1479 | 0.010 |
Why?
|
Length of Stay | 1 | 2012 | 6526 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2004 | 2360 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9549 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2006 | 6236 | 0.010 |
Why?
|
Insulin | 1 | 2011 | 6610 | 0.010 |
Why?
|
Electroencephalography | 1 | 2012 | 6317 | 0.010 |
Why?
|
Models, Statistical | 1 | 2011 | 5110 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 30266 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2012 | 7957 | 0.010 |
Why?
|
Prevalence | 1 | 2008 | 15879 | 0.010 |
Why?
|
Quality of Life | 1 | 2011 | 13510 | 0.010 |
Why?
|